© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Disease in the Elderly Patient A Global Perspective.

Slides:

Advertisements

Similar presentations

Cardiovascular Ischemic Heart Disease Group E

Advertisements

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.

Slide Source: Lipids Online Slide Library Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 5804 patients aged 70–82.

Copyright © 2008 Delmar. All rights reserved. Chapter 21 Populations with Chronic Diseases.

Peterson-Kaiser Health System Tracker How does the quality of the U.S. healthcare system compare to other countries?

Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and

Hospitalizations for Severe Sepsis Among Elderly Medicare Beneficiaries William Buczko, Ph.D. Research Analyst Centers for Medicare & Medicaid Services.

Did you know?? people died from chronic diseases in 2005.

Surveillance of Heart Diseases and Stroke Using Centers for Medicare and Medicaid (CMS) Data: A Researcher’s Perspective Judith H. Lichtman, PhD MPH Associate.

Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.

Quality of Care and Outcomes in Patients with Diabetes Hospitalized with Ischemic Stroke Findings From Get With The Guidelines-Stroke Reeves MJ; Vaidya.

1 National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994–2004 CIHR Team Grant.

Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.

CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.

St. Clair Health Care Commission Mobilizing for Action through Planning & Partnership Community Health Status Assessment.

Implementing screening and care management  NHI provides periodical health examination age once every 3 year ≧ 65 once every year  Provides integrated.

Robin A. Cohen, PhD National Center for Health Statistics National Conference on Health Statistics August 7, 2012 Financial burden of medical care: Looking.

Medicare’s Disease Management Activities Stuart Guterman Director, Office of Research, Development, and Information Centers for Medicare & Medicaid Services.

© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Aging.

Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.

VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.

Informing Public Policy to Address Health Care Disparities Boisey Barnes, MD, F.A.C.C. Founding Member and Trustee Association of Black Cardiologists.

Trauma in the elderly 18-1 TRAUMA IN THE ELDERLY.

Peterson-Kaiser Health System Tracker How does the quality of the U.S. healthcare system compare to other countries?

Quality Improvement Initiatives. National Service Framework for Coronary Heart Disease-UK Cooperative Cardiovascular Project (CCP)-USA National Registry.

Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.

Through its Quality efforts, the is… Supporting the appropriate use of new, transformational technologies and therapies Moving from a volume-to-value.

Health and Health Care  Goals  To explore trends in aging and health  To understand various social determinants in health  To examine different health.

LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.

RISK STRATIFICATION. Established by the CACR in Sept National Guidelines Committee The committee acknowledged the support of the Canadian Cardiovascular.

Cerebro-Vascular Pathology of Elderly diabetics 72 case-studies S. Hannat - R. Chermat - R. Malek Internal Medical Service University Hospital Centre Setif.

Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,

Parks and Chronic Disease Management ●Diabetic individuals taking 30-minute walks in a forest experienced much lower blood glucose levels than the same.

The Costs of Chronic Disease

Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.

Spinal Cord Injury The average age of our patients with traumatic spinal cord injuries in 2013 was 46 years. The average age of our.

Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.

Source: Community Health Status Report, HRSA Age Distribution: Wayne County, MI.

CVD MEETING 7/9/01: main topics CV CLINIC WITH SCREEN SHOTS AND AUDIT MANAGEMENT PROTOCOL WITH DRUGS AND RISK CALCULATION CHARTS ASPIRIN AUDIT.

R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.

© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Cardiovascular Risk: A global perspective

Discontinuation of medication after nonfatal event: MI

US Burden of Disease and Injury Study, 1996

Patient populations by study group figure 10

Target: Stroke Honor Roll

Cardiovascular Disease (CVD) in Texas

Achieving Long-Term Protection Post-MI

The Burden of Hospital-Associated Venous Thromboembolism

Progress and Promise in RAAS Blockade

EUCLID Trial design: Patients with peripheral arterial disease (PAD) were randomized to ticagrelor 90 mg twice daily (n = 6,930) vs. clopidogrel 75 mg.

برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی

Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD

Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population

Rounded incidence values (%) of renal and nonrenal events

VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =

Cardiovascular disease: Leading cause of death

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

The US Renal Data System “Pie Chart of Death”

Academic Perspective on Inequalities:Stroke

Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population

Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?

(p for noninferiority < 0.001)

Nat. Rev. Cardiol. doi: /nrcardio

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

Additional benefit of PCSK9 inhibition in high risk patients after myocardial infarction A FOURIER subanalysis Primary endpoint: composite of CV death,

Presentation transcript:

© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Disease in the Elderly Patient A Global Perspective

© Continuing Medical Implementation ® …...bridging the care gap Percent Aged 65 and Over: 2000

© Continuing Medical Implementation ® …...bridging the care gap Percent Aged 65 and Over: 2030

© Continuing Medical Implementation ® …...bridging the care gap

The Changing Face of Heart Disease and Stroke in Canada

© Continuing Medical Implementation ® …...bridging the care gap Hospitalization for All Cardiovascular Disease by Age

© Continuing Medical Implementation ® …...bridging the care gap Hospitalizations for Ischemic Heart Disease

© Continuing Medical Implementation ® …...bridging the care gap Hospitalizations for Acute MI

© Continuing Medical Implementation ® …...bridging the care gap Hospitalization Rates for Cerebrovascular Disease by Age

© Continuing Medical Implementation ® …...bridging the care gap Hospitalizations for Cerebrovascular Disease

© Continuing Medical Implementation ® …...bridging the care gap Hospitalization Rates for CHF

© Continuing Medical Implementation ® …...bridging the care gap Burden of Cardiovascular Disease If we can’t cope now, how will we cope in years? What can we do to prevent the onslaught of CV disease? Are we just delaying the inevitable? Compressing morbidity?